AST-001 versus placebo for social communication in children with autism spectrum disorder: A randomized clinical trial.

Psychiatry Clin Neurosci · 2025 · PMC11693980 · PMID 39425256

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

marginal significanceno p-value reported

In previous autism trials, buzmetanide 25 and intranasal oxytocin 28 showed marginal significance toward more improvement on the SRS, implying better efficacy for core symptoms in younger children with ASD.

also in 5,069 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.